Search Videos and More

Showing 13 - 24 of 35 results

Previous| 1 | 2 | 3 |Next


Drug Combination Found to Keep Chronic Lymphocytic Leukemia in Young Patients in Remission for Several Years News

Drug Combination Found to Keep Chronic Lymphocytic Leukemia in Young Patients in Remission for Several Years

A new study by Dana-Farber Cancer Institute researchers suggests that a 2.5-year regimen involving ibrutinib and chemoimmunotherapy can provide deep, and lasting remissions for patients with chronic lymphocytic leukemia (CLL).
Molecular Analysis Advances Risk Profiling and Assessment of Immunotherapy Response in Smoldering Myeloma News

Molecular Analysis Advances Risk Profiling and Assessment of Immunotherapy Response in Smoldering Myeloma

Molecular and genetic research by scientists at Dana-Farber Cancer Institute has advanced the categorization of different risk groups in patients with smoldering myeloma, a premalignant condition that can – but doesn’t always – progress to the blood cancer, multiple myeloma.
American Society of Hematology (ASH) Annual Meeting News

American Society of Hematology (ASH) Annual Meeting

As leaders in blood and blood cancer research, physicians and scientists from Dana-Farber Cancer Institute shared advances and insights at the 63rd Annual Meeting of the American Society of Hematology (ASH) on December 11–14, 2021 in Atlanta, Georgia
New Study Reveals Elevated Rates of Blood Cancer Precursor Condition in Groups at High Risk for Multiple Myeloma News

New Study Reveals Elevated Rates of Blood Cancer Precursor Condition in Groups at High Risk for Multiple Myeloma

The first results from the largest screening study yet conducted in the United States of individuals at above-average risk for the blood cancer multiple myeloma have revealed higher rates of a myeloma precursor condition in older adults who are Black or who have a close family member with a current or past blood cancer.
ASH 2021 Featured Oral Presentations Document

ASH 2021 Featured Oral Presentations

The Annual Meeting of the American Society of Hematology (ASH) will take place December 11-14th. To keep-up with latest advances, the live schedule of oral presentations by Dana-Farber faculty is attached for your convenience.
Discovery May Lead to Expanded Donor Pool for Stem Cell Transplants for Patients with Cancer News

Discovery May Lead to Expanded Donor Pool for Stem Cell Transplants for Patients with Cancer

Researchers find that in many cases people with a condition known as clonal hematopoiesis can safely serve as stem cell transplant donors.
Finding New Targets for Acute Myeloid Leukemia in Children News

Finding New Targets for Acute Myeloid Leukemia in Children

Looking for genes AML needs for everyday survival turned up two strong ‘hits’ to pursue for therapeutic development.
Study Results Support Stem Cell Transplantation for Older Patients with Myelodysplastic Syndromes News

Study Results Support Stem Cell Transplantation for Older Patients with Myelodysplastic Syndromes

Although stem cell transplantation is the only current therapy with the potential to cure myelodysplastic syndromes (MDS), it is rarely used as an initial treatment for older patients because it hasn’t been proven superior to other therapies. New research by Dana-Farber Cancer Institute investigators stands to overturn that practice.
Mantle Cell Lymphoma Clinical Trial Document

Mantle Cell Lymphoma Clinical Trial

Targeted combination therapy for mantle cell lymphoma with minimal residual disease assessment.
Clinical Trial Spotlight: Venetoclax plus Chemotherapy for Older Patients with Acute Lymphoblastic Leukemia (ALL) Video

Clinical Trial Spotlight: Venetoclax plus Chemotherapy for Older Patients with Acute Lymphoblastic Leukemia (ALL)

Dr. Marlise Luskin, a specialist in the Adult Leukemia Program at Dana-Farber Cancer Institute, explains an innovative trial that combines the BCL2 inhibitor, venetoclax with chemotherapy for older patients with ALL.
Stem Cell Transplant Beneficial for Older Patients with Myelodysplastic Syndrome Video

Stem Cell Transplant Beneficial for Older Patients with Myelodysplastic Syndrome

New research shows stem cell transplant represents the best therapeutic approach for older individuals with myelodysplastic syndrome. Dana-Farber Cancer Institute's Corey Cutler, MD, MPH, FRCPC explains more.
Treatment for Adults with Acute Lymphoblastic Leukemia Video

Treatment for Adults with Acute Lymphoblastic Leukemia

Marlise Luskin, MD, MSCE, a leukemia specialist at Dana-Farber Cancer Institute describes treatment for adults with acute lymphoblastic leukemia (ALL). She explains treatment considerations for younger adults and older adults with ALL.

Showing 13 - 24 of 35 results

Previous| 1 | 2 | 3 |Next